Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou can inject Wegovy into the buttocks, but it is not one of the three sites licensed in the UK. The three approved injection sites are the abdomen, the outer thigh, and the upper arm — and sticking to these matters more than it might seem. Wegovy is a prescription-only medicine; suitability and technique are confirmed through a clinical assessment, not assumed. Here is what the evidence and the product guidance say about where to inject, and why the list is the list it is.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You have your Wegovy pen out. Maybe it arrived that morning in a plain, unbranded box tracked through DPD. Now you are standing in the bathroom wondering whether the buttock is an option, it feels like a lot of surface area, it seems logical, and plenty of people mention it online.
The short answer is: the buttock is not one of the sites included in the UK licensed guidance for Wegovy. That guidance specifies the abdomen (stomach area), the outer thigh, and the outer area of the upper arm. Those three sites were chosen for the clinical trial programme and validated in terms of consistent absorption, predictable tissue depth, and practical self-injection, the buttock was not part of that validated set.
It is not that the buttock is uniquely dangerous. It is that injecting into an unlicensed site means you are operating outside the evidence base for how the medicine behaves. Absorption may differ; you may inadvertently inject into muscle rather than subcutaneous fat; you lose the assurance that the pharmacokinetics match what the trials established. For a medicine you are relying on for real results, that is a meaningful gap.
The NHS medicines page for semaglutide provides patient-level guidance on Wegovy, and the Patient Information Leaflet included with every pen remains the most specific instruction for technique.
Subcutaneous injection requires reaching the fat layer just beneath the skin without going into muscle. The three licensed sites all have a reliable subcutaneous fat layer across the range of body compositions that the trial populations represented. The outer abdomen is the most commonly used spot: easy to reach, straightforward to pinch, and predictably fatty in most adults. The outer thigh works well for people who prefer to sit during injection. If you are curious about whether you can inject Wegovy in your arm, the upper arm, usually the outer-mid section, is a licensed site that suits some people but can be harder to self-administer, a family member or carer can help.
Rotation matters as much as site selection. Injecting repeatedly into the same spot causes lipohypertrophy, a thickened, hardened lump under the skin that looks a little like a pea or small knot. Once that tissue is affected, absorption from that spot becomes erratic. The guidance is to move each injection at least 1–2 cm from where you injected last time, and to cycle properly between all three sites rather than always defaulting to one favourite spot.
If you are wondering whether injecting in the same spot each time is safe, the straightforward answer is: it is not recommended, for exactly the reason above. Rotation is part of the technique, not an optional detail.
The outer abdomen should avoid a roughly 5 cm radius around the navel. Do not inject into skin that is bruised, broken, tender, or shows any redness. If you are also injecting anything else (insulin, for example), keep the sites separate.
Mild reactions at the injection site are common, particularly in the early weeks. Redness, slight swelling, itching, or bruising that fades within a day or two are normal and not a reason to stop. Poor technique (not pinching enough skin, injecting too fast, not letting the skin dry after cleaning) tends to make these reactions worse.
A more persistent lump, significant pain, spreading redness, or any signs of infection are different. Those warrant a call to your prescriber or, if the symptoms are severe, urgent medical attention. You can also report any suspected side effect through the MHRA's Yellow Card scheme, which helps regulators monitor medicines in real-world use.
Occasionally people ask about reactions more broadly, whether a red patch is normal, or how to tell a reaction from something more significant. Our guide to Wegovy injection-site reactions covers this in more detail.
Technique is one of the most practical things a prescriber can walk you through at consultation. If you are finding injections uncomfortable or are unsure whether you are doing it right, speaking to our prescribers costs nothing and can save you a lot of doubt.
Two related questions come up frequently once people start thinking carefully about technique. The first is whether injecting a cold pen causes more discomfort or affects the medicine. The second is whether the same needle should be reused. Both have clear answers.
Wegovy pens are stored in the fridge. Taking the pen straight from the fridge and injecting immediately can make the injection sharper and increase the likelihood of a site reaction. Letting it sit at room temperature for a short while before injecting is widely recommended, your Patient Information Leaflet gives the specific timing. If you want more detail, our guide on injecting Wegovy cold covers what actually happens.
On needle changes: each pen should use a new needle for each injection. Reusing needles means they blunt quickly, which increases discomfort and the risk of site reactions, and it raises hygiene concerns. If you find yourself running low, compatible replacement needles are available from our pharmacy.
For anyone wondering about the upper arm as a site, our page on injecting Wegovy in the arm explains what to do if you find the other two sites difficult. And if you are concerned you may have made a technique error already, what happens if you inject Wegovy incorrectly is answered clearly there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.